Administered by:
A thread for the fourteen #MECFS and related research papers from w/c 27th Feb 2023.
Links will be to our forum discussion threads, where abstracts, links to paper, analysis and discussion can be found. Please note that inclusion in this list does not equal recommendation.
1/15
Brainstem volume changes in ME/CFS and long COVID patients - Thapaliya, Barnden et al
2/15
Skin Temperature Circadian Rhythms and Dysautonomia in ME/CFS: The Role of Endothelin-1 in the Vascular Tone Dysregulation - Cambras et al
3/15
Autoantibody Correlation Signatures in Fibromyalgia and ME/CFS: Association with Symptom Severity - Ryabkova et al
4/15
Health system support among patients with ME/CFS in Switzerland - Tschopp et al.
5/15
Non-pharmacological interventions for self-management of fatigue in adults: An umbrella review of potential interventions to support patients recovering from critical illness - Brown et al.
6/15
The Conners Continuous Performance Test CPT3™: Is it a reliable marker to predict neurocognitive dysfunction in Myalgic encephalomyelitis/chronic fatigue syndrome? - Fernández-Quirós et al.
7/15
ME/CFS and fibromyalgia: PR3-versus MPO-ANCA-associated vasculitis, an exploratory cross-sectional study - van Eeden et al
8/15
Stress, Asthenia, and Cognitive Disorders - Vasenina et al.
https://www.s4me.info/threads/stress-asthenia-and-cognitive-disorders-2023.32109/
9/15
Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells — Nikesjö et al.
10/15
Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learning — Patel et al.
11/15
One-Year Adverse Outcomes Among US Adults With Post–COVID-19 Condition vs Those Without COVID-19 in a Large Commercial Insurance Database — Andrea DeVries et al.
12/15
Structural brain changes in patients with post-COVID fatigue: a prospective observational study — Josephine Heine et al.
13/15
Neurocognitive and psychiatric symptoms following infection with COVID-19: Evidence from laboratory and population studies — Hall PA et al.
14/15
Cystatin-c May Indicate Subclinical Renal Involvement, While Orosomucoid Is Associated with Fatigue in Patients with Long-COVID Syndrome — Zavori et al.
15/15